What non-pharmaceutical policy tools do governments have to combat the COVID-19 public health and economic crisis?

1/8
#EconTwitter
Mask mandates are a low-hanging fruit (yet to be adopted in all US states). A great example: one person infected 27 customers at a Starbucks. How many employees were infected? None. They were all wearing masks.
https://twitter.com/samkimasia/status/1297116978964905984?s=20

2/8
Social distancing measures. One person infected 12 out of 17 business class passengers (including all adjacent passengers) on a 10-hour flight in March, when masks were not common. Only 2 other passengers in all the other cabins were infected.
https://twitter.com/sewonhur/status/1333902814356107266?s=20

3/8
Stay-at-home subsidies are effective at saving lives and increasing output, as I show in recent work ( https://doi.org/10.24149/gwp400r1). Subsidies for unemployment (PUA/PUC) and firms (PPP) are a step in the right direction.

5/8
Infectious diseases have externalities. How do economists deal with externalities? For COVID-19, a Pigouvian tax on consumption and/or labor can be effective at mitigating the spread (and also fund the stay-at-home subsidies)
https://doi.org/10.24149/gwp400r1

6/8
Lockdowns can save lives, but are more costly and less effective than subsidies/taxes, as shown in the figure below.
https://doi.org/10.24149/gwp400r1

7/8
Finally, the arrival of a vaccine warrants stronger, not weaker, mitigation efforts, as shown by @andyecon @DirkKrueger7 @Jonheathcote , and Rios-Rull ( http://doi.org/10.3386/w27046 ), + many others.

8/8
You can follow @sewonhur.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.